Table 3.
Fasting Plasma GLP-1 (pmol/L) | |||||
---|---|---|---|---|---|
Group L (<1.83) n = 34 |
Group H * (1.83–3.32) n = 34 |
p-Value | Decline of 1 pmol/L as a Continuous Variable | p-Value | |
Model 1 | 2.987 (1.108–8.049) | 1 | 0.031 | 1.556 (1.003–1.802) | 0.049 |
Model 2 | 3.121 (1.133–8.603) | 1 | 0.028 | 1.622 (1.091–1.843) | 0.030 |
Model 3 | 3.410 (1.160–10.023) | 1 | 0.026 | 1.673 (1.173–1.870) | 0.018 |
Data are expressed as OR (95% CI). * 1 as a reference value. Model 1: unadjusted. Model 2: adjusted for age, gender, fasting plasma glucose, HbA1c, C-peptide, and creatinine. Model 3: adjusted for Model 2 plus the use of ACE inhibitors or ARBs, SGLT-2 inhibitors, and DPP-4 inhibitors.